31OT cell therapy with EBV-specific cytotoxic T-lymphocytes for patients with nasopharyngeal carcinoma

Pedrazzoli, P Comoli, P Secondino, S Gurrado, A Pagani, A Zecca, M

Permalink

Open Access

Copyright Clearance Process

This item is open access.

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Pedrazzoli, P
dc.contributor.author	Comoli, P
dc.contributor.author	Secondino, S
dc.contributor.author	Gurrado, A
dc.contributor.author	Pagani, A
dc.contributor.author	Zecca, M
dc.date.accessioned	2022-04-01T05:47:55Z
dc.date.available	2022-04-01T05:47:55Z
dc.date.issued	2018-12-01
dc.identifier.citation	Annals of Oncology, 2018, 29, (suppl_10), pp. x11
dc.identifier.issn	0923-7534
dc.identifier.uri	http://hdl.handle.net/10453/155893
dc.language	en
dc.publisher	Elsevier BV
dc.relation.ispartof	Annals of Oncology
dc.relation.isbasedon	10.1093/annonc/mdy485
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1112 Oncology and Carcinogenesis
dc.subject.classification	Oncology & Carcinogenesis
dc.title	31OT cell therapy with EBV-specific cytotoxic T-lymphocytes for patients with nasopharyngeal carcinoma
dc.type	Journal Article
utslib.citation.volume	29
utslib.for	1112 Oncology and Carcinogenesis
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
utslib.copyright.status	open_access	*
dc.date.updated	2022-04-01T05:47:53Z
pubs.issue	suppl_10
pubs.publication-status	Published
pubs.volume	29
utslib.citation.issue	suppl_10

Please use this identifier to cite or link to this item: